These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26578115)

  • 1. Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development.
    Bhardwaj R; Shakri AR; Hans D; Gupta P; Fernandez-Becerra C; Del Portillo HA; Pandey G; Chitnis CE
    Protein Expr Purif; 2017 Aug; 136():52-57. PubMed ID: 26578115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.
    Martinez FJ; Guillotte-Blisnick M; Huon C; England P; Popovici J; Laude H; Arowas L; Ungeheuer MN; Reimer JM; Carter D; Reed S; Mukherjee P; Chauhan VS; Chitnis CE
    Sci Rep; 2023 Aug; 13(1):13904. PubMed ID: 37626150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development.
    Sampath S; Carrico C; Janes J; Gurumoorthy S; Gibson C; Melcher M; Chitnis CE; Wang R; Schief WR; Smith JD
    PLoS Pathog; 2013; 9(6):e1003420. PubMed ID: 23853575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
    Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
    PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloning, expression and identification of Plasmodium vivax Duffy binding protein region II of central China isolate].
    Liu D; Xia H; Tao ZY; Chen Y; Fang Q; Wang XM; Sun X; Gao Y; Mai YQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):474-7. PubMed ID: 23236803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.
    Yazdani SS; Shakri AR; Mukherjee P; Baniwal SK; Chitnis CE
    Vaccine; 2004 Sep; 22(27-28):3727-37. PubMed ID: 15315853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan.
    Hoque MR; Elfaki MMA; Ahmed MA; Lee SK; Muh F; Ali Albsheer MM; Hamid MMA; Han ET
    Malar J; 2018 Aug; 17(1):297. PubMed ID: 30119671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of recombinant vaccine based on the receptor-binding domain of the Plasmodium vivax Duffy binding protein in Aotus monkeys.
    Arévalo-Herrera M; Castellanos A; Yazdani SS; Shakri AR; Chitnis CE; Dominik R; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):25-31. PubMed ID: 16291763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells.
    Valizadeh V; Zakeri S; Mehrizi AA; Mirkazemi S; Djadid ND
    Med Microbiol Immunol; 2016 Feb; 205(1):85-95. PubMed ID: 26243337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.
    Camargos Costa D; Pereira de Assis GM; de Souza Silva FA; Araújo FC; de Souza Junior JC; Braga Hirano ZM; Satiko Kano F; Nóbrega de Sousa T; Carvalho LH; Ferreira Alves de Brito C
    PLoS One; 2015; 10(6):e0131339. PubMed ID: 26107662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
    Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
    Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
    Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity and natural selection of Duffy binding protein of Plasmodium vivax Korean isolates.
    Ju HL; Kang JM; Moon SU; Bahk YY; Cho PY; Sohn WM; Park YK; Park JW; Kim TS; Na BK
    Acta Trop; 2013 Jan; 125(1):67-74. PubMed ID: 23031445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Barnes SJ; McHenry AM; George MT; Schloegel J; Adams JH
    Clin Vaccine Immunol; 2014 Sep; 21(9):1215-23. PubMed ID: 24964808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine specificity of Plasmodium vivax Duffy binding protein binding engagement of the Duffy antigen on human erythrocytes.
    Siddiqui AA; Xainli J; Schloegel J; Carias L; Ntumngia F; Shoham M; Casey JL; Foley M; Adams JH; King CL
    Infect Immun; 2012 Aug; 80(8):2920-8. PubMed ID: 22615246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
    He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.